(Q36882380)

16 August 2017

1 reference

title

Radiotherapy of glioblastoma (English)

1 reference

16 August 2017

1 reference

de Crevoisier R

1

1 reference

16 August 2017

Pierga JY

2

1 reference

16 August 2017

Dendale R

3

1 reference

16 August 2017

Feuvret L

4

1 reference

16 August 2017

Noël G

5

1 reference

16 August 2017

Simon JM

6

1 reference

16 August 2017

Mazeron JJ

7

1 reference

16 August 2017

publication date

1 January 1997

1 reference

16 August 2017

1 reference

16 August 2017

volume

1

1 reference

16 August 2017

issue

3

1 reference

16 August 2017

page(s)

194-207

1 reference

Intratumoral heterogeneity of malignant gliomas measured in vitro.

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Bromodeoxyuridine labeling index in glioblastoma multiforme: relation to radiation response, age, and survival.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

A randomized study of misonidazole and radiotherapy for grade 3 and 4 cerebral astrocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Fast neutrons in the treatment of grade IV astrocytomas

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Intra arterial chemotherapy with ACNU and radiotherapy in inoperable malignant gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Development of multiple lesions during radiation therapy and chemotherapy in patients with gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Interstitial iridium-192 implantation for malignant brain tumours. Part II: Clinical experience.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

The results of a randomised trial of mixed-schedule (neutron/photon) irradiation in the treatment of supratentorial Grade III and Grade IV astrocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Report of a randomised pilot study of the treatment of patients with supratentorial gliomas using neutron irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Misonidazole in radiotherapy of supratentorial malignant brain gliomas in adult patients: a randomized double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Descriptive epidemiology of cerebral gliomas in France.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Selection bias, survival, and brachytherapy for glioma

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Misonidazole combined with hyperfractionation in the management of malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Postoperative hypofractionated radiotherapy versus conventionally fractionated radiotherapy in malignant gliomas. A preliminary report on a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

External irradiation followed by an interstitial high activity iodine-125 implant “boost” in the initial treatment of malignant gliomas: NCOG study 6G-82-2 gliomas: NCOG study 6H-82-2

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Prognostic significance of preoperative MRI scans in glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Experience of boron-neutron capture therapy for malignant brain tumours--with special reference to the problems of postoperative CT follow-ups

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Clinical results of long-surviving brain tumor patients who underwent boron neutron capture therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Malignant glioma: patterns of failure following individually tailored limited volume irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Results of a randomized trial comparing intra-arterial cisplatin and intravenous PCNU for the treatment of primary brain tumors in adults: Brain Tumor Cooperative Group trial 8420A.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Adjuvant therapy with dibromodulcitol and BCNU increases survival of adults with malignant gliomas. EORTC Brain Tumor Group

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Brachytherapy for malignant recurrent and untreated gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Assumptions in the radiotherapy of glioblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Cell kinetic analysis of human brain tumors byin situ double labelling with bromodeoxyuridine and iododeoxyuridine

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Intratumoral oxygen pressure in malignant brain tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Pharmacology and phase I/II study of continuous intravenous infusions of iododeoxyuridine and hyperfractionated radiotherapy in patients with glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

The new WHO classification of brain tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Surgical resection and radiation therapy versus biopsy and radiation therapy in the treatment of glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Stud

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Randomized neutron dose searching study for malignant gliomas of the brain: results of an RTOG study. Radiation Therapy Oncology Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Boron neutron capture therapy (BNCT) for high-grade gliomas of the brain: a cautionary note

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Interstitial radiogold implantation for the treatment of recurrent high-grade gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Results of stereotactic brachytherapy used in the initial management of patients with glioblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Treatment results of stereotactic interstitial brachytherapy for primary and metastatic brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

National survey of patterns of care for brain-tumor patients

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Response of glioblastoma cell lines to low dose rate irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Preliminary results of interstitial 192Ir brachytherapy for malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Radiation therapy for malignant astrocytomas in adults

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG study

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Survival and prognosis of patients with astrocytoma with atypical or anaplastic features.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Attempted dose intensified cyclophosphamide, etoposide, and granulocyte colony-stimulating factor for treatment of malignant astrocytoma

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Radiation therapy in the treatment of glioblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Neutron interstitial brachytherapy for malignant gliomas: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Malignant astrocytoma. Hyperfractionated and standard radiotherapy with chemotherapy in a randomized prospective clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

High dose chemotherapy for the treatment of malignant brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Tolerance of nicotinamide and carbogen with radiation therapy for glioblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Radiotherapy of glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Radiosurgery in the initial management of malignant gliomas: survival comparison with the RTOG recursive partitioning analysis. Radiation Therapy Oncology Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Repair kinetics as a determining factor for late tolerance of central nervous system to low dose rate irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

The relationship between the technical accuracy of stereotactic interstitial implantation for high grade gliomas and the pattern of tumor recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

A randomized comparison of intra-arterial versus intravenous BCNU, with or without intravenous 5-fluorouracil, for newly diagnosed patients with malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Accelerated fractionation for high-grade cerebral astrocytomas. Preliminary treatment results

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Superfractionation radiation therapy in the treatment of malignant astrocytoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Hypofractionated radiation therapy in patients with glioblastoma multiforme: results of treatment and impact of prognostic factors.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Misonidazole and irradiation in the treatment of high-grade astrocytomas: Further report of the Vienna study group

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Interstitial thermoradiotherapy of brain tumors: preliminary results of a phase I clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

In vivo radiation sensitivity of glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Radiation and High-Dose Metronidazole in Supratentorial Glioblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Radiation and nitroimidazoles in supratentorial high grade gliomas: a second clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Conventional radiotherapy combined with carbogen breathing and nicotinamide for malignant gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

External beam radiotherapy: hard facts and painful realities

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

An analysis of dose-effect relationship in the radiotherapy of malignant gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Long term results of stereotactic brachytherapy used in the initial treatment of patients with glioblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

The hazard of accelerated tumor clonogen repopulation during radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS1278-3218%2897%2989765-X

7 January 2021

10.1016/S1278-3218(97)89765-X

Identifiers

DOI

1 reference

16 August 2017

1 reference